Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zenas BioPharma (ZBIO) Other Operating Expenses (2025)

Zenas BioPharma has reported Other Operating Expenses over the past 1 years, most recently at $166.7 million for Q4 2025.

  • Quarterly results put Other Operating Expenses at $166.7 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $171.7 million (changed N/A YoY), and the annual figure for FY2025 was $171.7 million, changed.
  • Other Operating Expenses for Q4 2025 was $166.7 million at Zenas BioPharma, up from $5.0 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for ZBIO hit a ceiling of $166.7 million in Q4 2025 and a floor of $5.0 million in Q3 2025.